Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 16,92116,940 of 20,252 grants

Completed OTHER RESEARCH-RELATED
Metabolite sensing through the HAT1 acetyltransferase as an anti-cancer target
NATIONAL CANCER INSTITUTE Ut Southwestern Medical Center United States 2021 – 2025

PROJECT SUMMARY/ABSTRACT This is an application for a K08 for Dr. Joshua Gruber, an Instructor of Medicine at Stanford University. Dr. Gruber wishes to establish himself as a clini...

$1.64M
USD
Active NON-SBIR/STTR RPGS
The regulation of mutant p53 protein accumulation in cancer: molecular basis and therapeutic potential
NATIONAL CANCER INSTITUTE Rutgers Biomedical and Health Sciences United States 2021 – 2026

Abstract Tumor suppressor p53 is the most frequently mutated gene in human cancer, including colorectal cancer (CRC). Many tumor-associated mutant p53 (mutp53) proteins not only lo...

$3.97M
USD
Active NON-SBIR/STTR RPGS
Dynamic µOCT for cellular tissue phenotyping
NATIONAL CANCER INSTITUTE Massachusetts General Hospital United States 2021 – 2026

Phenotyping cells and tissue is a critical function that spans basic science to clinical diagnosis. Yet, established methods for phenotyping cells in tissue are static, are evaluat...

$5.87M
USD
Completed NON-SBIR/STTR RPGS
Investigating Cellular Communication in the Tumor Microenvironment in Pancreatic Cancer
NATIONAL CANCER INSTITUTE Henry Ford Health System United States 2021 – 2025

PROJECT SUMMARY/ABSTRACT Pancreatic ductal adenocarcinoma (PDAC) is projected to become the 2nd leading cause of cancer-related deaths world-wide by 2030, largely due a lack of eff...

$748.9K
USD
Active NON-SBIR/STTR RPGS
Precision magnetic hyperthermia by integrating magnetic particle imaging
NATIONAL CANCER INSTITUTE Johns Hopkins University United States 2021 – 2026

Precision magnetic hyperthermia by integrating magnetic particle imaging Magnetic activation of magnetic iron oxide nanoparticles (MIONPs) offers considerable potential for numerou...

$6.07M
USD
Active OTHER RESEARCH-RELATED
Chromosomal Instability as a Marker and Mechanism of Radiation Response
NATIONAL CANCER INSTITUTE University of Wisconsin-Madison United States 2021 – 2026

ABSTRACT Human Papilloma Virus (HPV) causes nearly 5% of all cancers worldwide and is implicated in 95% of cervical and 70% of oropharyngeal cancers (OPC). Curative platinum-based...

$1.85M
USD
Active NON-SBIR/STTR RPGS
Elucidating the role of DNAPKcs in chromosomal break end joining and clastogen resistance
NATIONAL CANCER INSTITUTE Beckman Research Institute/City of Hope United States 2021 – 2026

SUMMARY. Kinase inhibitors targeting the catalytic subunit of the DNA-dependent protein kinase (DNAPKcs) are being developed to sensitize tumors to clastogenic (chromosomal-breakin...

$3.82M
USD
Active OTHER RESEARCH-RELATED
Spinal cord stimulation for the attenuation of chemotherapy-induced peripheral neuropathy and enhanced chemotherapeutic efficacy
NATIONAL CANCER INSTITUTE Johns Hopkins University United States 2021 – 2026

Project Summary Chemotherapy-induced peripheral neuropathy (CIPN) is a common dose-limiting side effect of cancer treatment drugs that often presents as debilitating pain in a stoc...

$2.82M
USD
Active NON-SBIR/STTR RPGS
Innate Immune Mechanisms Contributing to Cancer Growth in Obesity
NATIONAL CANCER INSTITUTE Stanford University United States 2021 – 2026

Project Summary/Abstract Colorectal cancer (CRC) is the second leading cause of cancer mortality in the United States, and obesity, which affects 40% of the population, not only in...

$6.91M
USD
Active OTHER RESEARCH-RELATED
Targeting an unrecognized checkpoint on T cell function in tumors
NATIONAL CANCER INSTITUTE Oregon Health & Science University United States 2021 – 2026

PROJECT SUMMARY/ABSTRACT A diverse accumulation of infiltrating immune cells is a prominent feature of nearly all cancers1. By directing the effector functions of cancer-killing T...

$2.46M
USD
Active NON-SBIR/STTR RPGS
Pediatric Preclinical In Vivo Testing Center for Pediatric Sarcoma and Other Solid Tumors
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2021 – 2026

ABSTRACT With recent enactment of the Research to Accelerate Cures and Equity (RACE) for Children Act, there is a growing impetus to identify pediatric indications for molecularly...

$7.3M
USD
Active NON-SBIR/STTR RPGS
Targeting CDK6 expression/activity in Ph+ and Ph1-like acute lymphoblastic leukemia (ALL)
NATIONAL CANCER INSTITUTE Thomas Jefferson University United States 2021 – 2026

Abstract Philadelphia-positive acute lymhoblastic leukemia (Ph+ ALL) and Ph1-like B-ALL account for most cases of “high-risk” adult B-ALL. Current therapies with tyrosine kinase in...

$6M
USD
Active NON-SBIR/STTR RPGS
THE ROLE OF SELENOPROTEIN SYNTHESIS PATHWAY IN ACUTE MYELOID LEUKEMIA
NATIONAL CANCER INSTITUTE Baylor College of Medicine United States 2021 – 2026

AML is the most common acute leukemia in adults, and it appears increasingly with age. Despite overall improvement in the treatment of leukemia, AML still carries a devastating pro...

$4.42M
USD
Active TRAINING, INDIVIDUAL
RNA Methylation in Cancer Plasticity and Drug Resistance
NATIONAL CANCER INSTITUTE University of Southern California United States 2021 – 2026

PROJECT SUMMARY/ ABSTRACT Cancer drug resistance occurs not only by selection of genetically resistant clones, but also through phenotypic plasticity via rapid induction of transcr...

$569.7K
USD
Active NON-SBIR/STTR RPGS
Writing to Heal: A Culturally Based Brief Expressive Writing Intervention for Chinese Immigrant Breast Cancer Survivors
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2021 – 2026

Project Summary/Abstract The unavailability of culturally competent mental health care for Chinese immigrant breast cancer survivors and their unmet psychological needs characteriz...

$5.58M
USD
Active NON-SBIR/STTR RPGS
Androgen receptor pathway inhibition through targeting PARP-2 in castration-resistant prostate cancer
NATIONAL CANCER INSTITUTE Brigham and Women'S Hospital United States 2021 – 2026

ABSTRACT Androgen receptor (AR) is ligand-activated transcription factor and a driver of prostate cancer (PCa). Understanding the molecular mechanisms of AR-mediated transcription...

$3.89M
USD
Active NON-SBIR/STTR RPGS
Cause and therapeutic impact of DNA-protein crosslink repair defect in myeloid leukemias
NATIONAL CANCER INSTITUTE Mayo Clinic Rochester United States 2021 – 2026

ABSTRACT Acute myeloid leukemias (AMLs) are a genetically heterogeneous group of clonal hematopoietic disorders characterized by accumulation of immature non-lymphoid marrow progen...

$3.46M
USD
Completed TRAINING, INDIVIDUAL
Investigating the structure and function of the human centromere and kinetochore
NATIONAL CANCER INSTITUTE University of Pennsylvania United States 2021 – 2024

Project Summary Accurate segregation of chromosomes during cell division is one of the most fundamental requirements in biology. Without proper chromosomal segregation, genetic inf...

$70.8K
USD
Active NON-SBIR/STTR RPGS
The role of CEACAM1 in oncogenic B-cell receptor signaling and immunotherapy in mantle cell lymphoma
NATIONAL CANCER INSTITUTE Beckman Research Institute/City of Hope United States 2021 – 2026

Abstract Mantle cell lymphoma (MCL) accounts for 6-8% of all non-Hodgkin lymphomas (NHLs). While substantial therapeutic advances have been achieved for other NHLs, MCL remains an...

$3.81M
USD
Active NON-SBIR/STTR RPGS
Pentraxin-3 in the Pathogenesis and Management of Triple-Negative Breast Cancer
NATIONAL CANCER INSTITUTE Beth Israel Deaconess Medical Center United States 2021 – 2026

SUMMARY Background. Triple-negative breast cancers (TNBCs) present with advanced histological grade and aggressive clinical behavior. They are overwhelmingly unresponsive to conven...

$4.34M
USD